Mike Pogose

Regulatory
After Brexit: Device regulations come under scrutiny
The U.K. has produced advice on how to launch medical devices on the market after the Brexit transition period ends on 1 January 2021. Regulatory expert Mike Pogose discusses how the new procedures will affect imaging manufacturers and their customers.
September 14, 2020
2016 07 06 11 22 59 854 Eu Uk Split 400
Page 1 of 1
Top Stories
Photo illustrating eco-responsibility, a theme that the SFR continues to champion at the JFR. The photograph shows a paper flower made by a patient (www.poeticmood.fr) who will be running craft workshops at the Patient Associations’ Village during JFR 2026. Participants will be invited to create their own JFR 2026 flower and take it home.
Organized Radiology Issues
Les patients d’abord! Patients first at this year’s JFR meeting
JFR president Prof. Isabelle Thomassin-Naggara discusses the importance of the human radiologist for patients, a key theme at this year’s congress.
Whats App Image 2026 09 17 At 15 24 59
Nuclear Medicine
IAEA Scientific Forum: Can automated planning shorten radiotherapy waits?
From left: moderator Christine Mhundwa with Dr. Claudio Tinoco Mesquita, Dr. Ariel Fariña Barrios, Dr. Dina Husseiny Salama, Dr. Umesh Mahantshetty, Dr. Ellen Kampman and Dr. Alejandro Mazal.
Nuclear Medicine
Radiation medicine aims to tackle cancer care inequalities in low-income countries
Whats App Image 2026 09 15 At 20 00 14
Nuclear Medicine
IAEA Scientific Forum: Where you live should not determine access to cancer care
Gonnie van Erp: “We still see interobserver differences in margin assessment.”
Interventional
CIRSE: Studies link ablation margins to liver tumor control
More in Home
Les patients d’abord! Patients first at this year’s JFR meeting
By Frances Rylands-Monk
JFR president Prof. Isabelle Thomassin-Naggara discusses the importance of the human radiologist for patients, a key theme at this year’s congress.
September 18, 2026
Photo illustrating eco-responsibility, a theme that the SFR continues to champion at the JFR. The photograph shows a paper flower made by a patient (www.poeticmood.fr) who will be running craft workshops at the Patient Associations’ Village during JFR 2026. Participants will be invited to create their own JFR 2026 flower and take it home.
IAEA Scientific Forum: Can automated planning shorten radiotherapy waits?
By Claudia Tschabuschnig
Research promising one-second treatment planning prompted discussion of workforce shortages and delays in cancer care at the IAEA Scientific Forum in Vienna.
September 17, 2026
Whats App Image 2026 09 17 At 15 24 59
Radiation medicine aims to tackle cancer care inequalities in low-income countries
By Claudia Tschabuschnig
Health experts discussed challenges facing cancer care in low income countries, the potential of theranostics as well as AI, covering various topics to bridge global health disparities at the IAEA Scientific Forum in Vienna.
September 16, 2026
From left: moderator Christine Mhundwa with Dr. Claudio Tinoco Mesquita, Dr. Ariel Fariña Barrios, Dr. Dina Husseiny Salama, Dr. Umesh Mahantshetty, Dr. Ellen Kampman and Dr. Alejandro Mazal.
IAEA Scientific Forum: Where you live should not determine access to cancer care
By Claudia Tschabuschnig
At the IAEA Scientific Forum in Vienna, politicians, health policymakers, ministers, and physicians came with a bunch of numbers on the stark differences in access to radiotherapy, nuclear medicine, and medical imaging, especially in low and middle income countries.
September 15, 2026
Whats App Image 2026 09 15 At 20 00 14
CIRSE: Studies link ablation margins to liver tumor control
By Claudia Tschabuschnig
Two studies presented at CIRSE 2026 linked adequate ablation margins to better liver tumor control. Measuring those margins consistently remains a challenge.
September 14, 2026
Gonnie van Erp: “We still see interobserver differences in margin assessment.”
ESHNR 2026 spotlights salivary gland perfusion and neck cyst origins
By Claudia Tschabuschnig
The society honoured Tim Beale and supported the next generation of radiologists at ESHNR 2026 in Budapest.
September 14, 2026
Img 7948
From the reading room to the front line and back to the saddle
By Oleksandr Berezovskyi
A radiologist's ride from Ukraine to Berlin.
September 11, 2026
U Kr6
Radical radiotherapy use rising for treating lung cancer
By Amerigo Allegretto
Radical radiotherapy use nearly doubled between 2010 and 2021 in lung cancer patients and correlates to improved five-year outcomes.
September 10, 2026
Lungs Red 400
CIRSE: Should drug-coated devices remain routine in leg artery treatment?
By Claudia Tschabuschnig
Could SWEDEPAD, two Swedish trials comparing drug-coated and uncoated devices for leg artery treatment, change practice? CIRSE experts debated patient benefits and long-term safety.
September 10, 2026
CIRSE 2026
CIRSE’s ‘Amazing Interventions’ go beyond conventional routes
By Claudia Tschabuschnig
From creating new biliary pathways to targeting elusive lymphatic leaks, specialists at CIRSE 2026 shared inventive interventions for patients with few remaining options.
September 9, 2026
Endovascular splenorenal shunt in chronic portal vein thrombosis presented by Dr. Carolin Sobotta University Medicine Goettingen Goettingen, Germany
ESHNR heads to Budapest with dental imaging, cancer updates and AI on the agenda
By Claudia Tschabuschnig
From dental MRI to imaging after cancer treatment, ESHNR 2026 brings practical challenges and emerging techniques to Budapest on September 10–12. Here’s what to watch for.
September 9, 2026
Eshnr 26 Promo Ppt Reg Now 1920x1080 V1 Red
CIRSE: Patient selection drives local treatment of lung tumours
By Claudia Tschabuschnig
Billed as a controversy session, a discussion of local treatments for lung tumors at CIRSE 2026 highlighted common ground: patient selection, lung preservation, and the complementary roles of radiotherapy and ablation.
September 8, 2026
20260905 081521 Art6424 Scaled
Page 1 of 92
Next Page